APA (7th ed.) Citation

Nasir, A., Bissonnette, R., Maari, C., DuBois, J., Pene Dumitrescu, T., Haddad, J., . . . Dalessandro, M. (2018). A phase 2a randomized controlled study to evaluate the pharmacokinetic, safety, tolerability and clinical effect of topically applied Umeclidinium in subjects with primary axillary hyperhidrosis. Journal of the European Academy of Dermatology & Venereology, 32(1), 145. https://doi.org/10.1111/jdv.14651

Chicago Style (17th ed.) Citation

Nasir, A., R. Bissonnette, C. Maari, J. DuBois, T. Pene Dumitrescu, J. Haddad, Y. Yamaguchi, and M. Dalessandro. "A Phase 2a Randomized Controlled Study to Evaluate the Pharmacokinetic, Safety, Tolerability and Clinical Effect of Topically Applied Umeclidinium in Subjects with Primary Axillary Hyperhidrosis." Journal of the European Academy of Dermatology & Venereology 32, no. 1 (2018): 145. https://doi.org/10.1111/jdv.14651.

MLA (9th ed.) Citation

Nasir, A., et al. "A Phase 2a Randomized Controlled Study to Evaluate the Pharmacokinetic, Safety, Tolerability and Clinical Effect of Topically Applied Umeclidinium in Subjects with Primary Axillary Hyperhidrosis." Journal of the European Academy of Dermatology & Venereology, vol. 32, no. 1, 2018, p. 145, https://doi.org/10.1111/jdv.14651.